期刊文献+

门冬氨酸钾镁联用培哚普利治疗慢性心力衰竭的临床观察

暂未订购
导出
摘要 目的 观察门冬氨酸钾镁联用培哚普利治疗慢性心力衰竭的疗效。方法 对 117例慢性心力衰竭患者分两组 ,其中 ,59例病人作为治疗组 ,在常规强心、利尿的基础上 ,使用培哚普利口服、加用静脉滴注门冬氨酸钾镁 ;58例病人作为对照组 ,常规使用强心、利尿药物的基础上 ,加用培哚普利口服。比较其两组的疗效及并发症的发生率。结果 治疗组的显效率为 59.3 %与对照组 (2 2 .4% )相比 ,有明显差异 (P <0 .0 1)疗效出现时间治疗组 (3 .6± 0 .8)d ,较对照组 (6.3± 0 .6)d短 (P <0 .0 5) ;低血钾、洋地黄中毒、室性及房性心律失常发生率明显低于对照组。结论 门冬氨酸钾镁联用培哚普利治疗心力衰竭 ,具有简单易行 ,疗效显著 。
作者 黎励文
出处 《广东药学》 2003年第4期35-37,共3页 Guangdong Pharmaceutical Journal
  • 相关文献

参考文献8

  • 1中华心血管病杂志编委会.全国镁离子在心血管病的临床应用研讨会纪要[J].中华心血管病杂志,1998,26(3):238-238.
  • 2张宁仔 杜日映.心血管科进修医师必读[M].北京:人民卫生出版社,1997.372.
  • 3杨屹云,李宪伦,钱端,王云,秦延莉,柯元南.门冬氨酸钾镁治疗急性心肌梗死的临床观察[J].中华老年心脑血管病杂志,2001,3(4):233-235. 被引量:4
  • 4林曙光,陈鲁原,苏诚坚,李广镰,王景峰,梅克治,陆东风,曾昭华,曾冲,谭桂明,韦建瑞,李国强.培哚普利和依那普利治疗心力衰竭首剂低血压反应差异的临床研究[J].中华心血管病杂志,2001,29(1):22-24. 被引量:5
  • 5Arsortian MA. Magnesium and cardiovascular disease[ J ].Prog Cardiovasc Dis, 1993,35 ( 4 ) ;271.
  • 6Reinhart RA. Clinical correlates of the molecular and culluar actions of magnesium on the cardiovascular system[J].Am Heart, 1991,121:1513 - 1521.
  • 7Leonetti G, Cuspidi C. Choosing the right ACEI: A guide to selection [ J ]. Drugs, 1995,49:516 - 535.
  • 8Moser M. Angioten-converting enzyme inhibitors ,angiotensin Ⅱ receptor antagonists and calcium channel blocking agents: A review of potential benefits and possible adverse reactions [ J ]. J Am Cardiol, 1997,29 :1414 - 1421.

二级参考文献10

  • 1Packer M,New Engl J Med,1986年,315卷,847页
  • 2Barbarm LB,Jacob PV.Role of dietary magnesium deficiency in the pressor and arrhythmogenic response to epinephrine in the intact dog[J].Am heart J,1994,127:96-102
  • 3Parikka H,Toivonen L,Naukkarinen V,et al.Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infaretion[J].Eur Heart J,1999,20:111-120
  • 4Raghu C,Peddeswara RP,Seshagiri RD,Protective effect of intravenous magnesium in acute myocardial infarction following thrombolyt6ic therapy[J].Int J Cardiol,1999,71:209-215
  • 5Shechter M,Hod H,Chouraqui P,et al.Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy[J].Am J Cardiol,1995,75:321-323
  • 6Garcia LA,Dejong SC,Martin SM,et al.Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model[J].J Am Coll Cardiol,1998,32:536-539*
  • 7Christensen CW,Rieder MA,Silverstein EL,et al.Magnesium sulfate reduces myocardial infarct size when administered before but not5 after coronary reperfusion in a canine model[J].Ci8rculation,1995,92:2617-2621
  • 8Ravn HB,Moeldrup U,Broodes CI,et al.Intravenous magnesium reduces infarct size fter ischemia/reperfusion injury combined with a thrombogenic lesion in the left anterior descending artery[J].Arterioscler-Thromb-Vasc-Biol,1999.19:569-574
  • 9Shechter M,Merz CN,Paul LM,et al.Oral magnesium supplementation in hibits platelet-dependent thrombosis in patiems with coronary artery diseasw[J].Am J Cardiol,1999,84:152-156
  • 10Gyamlani C,Patikh C,Kulkarni AG,Benefits of magnesium in acute myocardial infarction:timing is crucial[J].Am Heart J,2000,139:703

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部